Gaber S A, Mazzola G, Berrino M, Canale L, Cornaglia M, Ghali I, Sergio Curtoni E, Amoroso A
Italian Hospital Umberto I, Turin.
Diabetes Care. 1994 Nov;17(11):1341-4. doi: 10.2337/diacare.17.11.1341.
To analyze the association between human leukocyte antigen (HLA) and insulin-dependent diabetes mellitus (IDDM) in the Egyptian population for the first time and, thus, to determine the frequency of risk-associated alleles identified by a genomic HLA class II typing. Egyptians are genetically classified as North Africans and considered to be between Caucasoids and Africans (closer to Caucasoids).
HLA class II typing was performed for 50 IDDM patients and 50 healthy control subjects by a restriction fragment-length polymorphism (RFLP) technique. The analysis of position 57 of the DQB1 molecules was conducted by polymerase chain reaction and specific sequence oligonucleotide hybridization.
The frequency of DRB10301-DRB30201-DQA10501-DQB10201 haplotype was 43.9% in the IDDM patients and 7.1% in the control subjects (P < 0.00001), reflecting the increased prevalence of DQA10501 susceptibility allele coding for arginine (Arg) in position 52 and DQB10201 susceptibility allele non-coding aspartic acid (Asp) at position 57. Alleles DQB10601 and 0603, both carrying Asp at position 57 of the beta-chain, and DQA10103, encoding a non-Arg 52 alpha-chain, were significantly decreased among the IDDM patients. The presence of four susceptibility residues (two DQA1 Arg 52+ and two DQB1 Asp 57-) conferred the highest relative risk at 20.2. On the other hand, homozygous genotypes for DQA1 non-Arg 52 and DQB1 Asp 57 were found only in the control group.
IDDM susceptibility and resistance in the Egyptian population is strongly associated with the expressed DQ alpha- and beta-heterodimers in a dose-effective manner, as already defined in many different ethnic groups.
首次分析埃及人群中人类白细胞抗原(HLA)与胰岛素依赖型糖尿病(IDDM)之间的关联,从而确定通过基因组HLA II类分型鉴定的风险相关等位基因的频率。埃及人在遗传学上被归类为北非人,被认为介于白种人和非洲人之间(更接近白种人)。
采用限制性片段长度多态性(RFLP)技术对50例IDDM患者和50例健康对照者进行HLA II类分型。通过聚合酶链反应和特异性序列寡核苷酸杂交对DQB1分子第57位进行分析。
DRB10301-DRB30201-DQA10501-DQB10201单倍型在IDDM患者中的频率为43.9%,在对照者中为7.1%(P<0.00001),这反映了编码第52位精氨酸(Arg)的DQA10501易感等位基因和第57位非编码天冬氨酸(Asp)的DQB10201易感等位基因的患病率增加。在IDDM患者中,β链第57位均携带Asp的DQB10601和0603等位基因以及编码非Arg 52α链的DQA10103等位基因显著减少。四个易感残基(两个DQA1 Arg 52+和两个DQB1 Asp 57-)的存在赋予了最高相对风险,为20.2。另一方面,仅在对照组中发现了DQA1非Arg 52和DQB1 Asp 57的纯合基因型。
如在许多不同种族中已定义的那样,埃及人群中的IDDM易感性和抗性与表达的DQα和β异二聚体以剂量效应方式密切相关。